AMLX
Amylyx Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website amylyx.com
- Employees(FY) 374
- ISIN US03237H1014
Performance
-3.17%
1W
-8.96%
1M
-88.48%
3M
-84.91%
6M
-87.57%
YTD
-93.41%
1Y
Profile
Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases. The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the United States and marketed as ALBRIOZA for the treatment of ALS in Canada. It is also developing AMX0114 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Investment Analysis Report: AMLX
Overview
In this investment analysis report, we will delve into a comprehensive analysis of AMLX, a company operating in the Health Technology sector within the Pharmaceuticals: Major industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating ...
Technical Analysis of AMLX 2024-05-10
Overview:
In analyzing the technical indicators for AMLX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been declining steadily, indi...
Recent News & Updates
- 2024-05-13 19:25
- 2024-05-10 03:54
Amylyx Pharmaceuticals Reports Q1 2024 Financial Results(Yahoo Finance)
- 2024-05-10 00:47
- 2024-05-08 20:15
- 2024-05-08 20:15
- 2024-05-08 19:00
- 2024-05-08 19:00
- 2024-05-07 21:00
- 2024-05-01 21:00
- 2024-04-30 00:02
Trials to watch: Four ALS drugs to keep an eye on(Yahoo Finance)
- 2024-04-10 03:14
- 2024-04-09 21:00
- 2024-04-07 21:00
- 2024-04-04 01:20
- 2024-04-03 22:05
- 2024-04-03 19:52
- 2024-04-03 19:43
- 2024-04-03 19:07
- 2024-04-03 19:00
- 2024-04-03 18:09
Amylyx to pull ALS drug from market in rare move(Yahoo Finance)
- 2024-04-02 17:45
- 2024-04-01 07:30
- 2024-03-26 19:36
European study finds popular ALS drug ineffective(Yahoo Finance)
- 2024-03-25 02:33
- 2024-03-14 06:49
3 Pharma Stocks to Sell in March Before They Crash & Burn(Yahoo Finance)
- 2024-03-13 21:00
- 2024-03-12 22:00
- 2024-03-12 21:03
Analysts on Wall Street Lower Ratings for These 10 Stocks(Insidermonkey)
- 2024-03-11 19:55
- 2024-03-11 00:34
Page 1 of 7
previousnext